Soluble adhesion molecules: Surrogate markers of cardiovascular disease?

Nutrition Reviews

Volumn 61, Issue 2, 2003, Pages 63-68

  Meydani, Mohsen ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; n 3 PUFA; Oleic acid; Soluble adhesion molecules; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CELL ADHESION MOLECULE; FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; BIOLOGICAL MARKER;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; FAT INTAKE; FRUIT; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; REVIEW; VEGETABLE; AGED; BLOOD; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0038006953     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2003.febr.63-68     Document Type: Review

References (72)

1. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Ann Rev Med. 1994;45:361-378.
2. Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol. 1992;71:76-87.
3. Cartwright JE, Whitley GSJ, Johnstone PA. The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp Cell Res. 1995;217:329-335.
4. Gorski A. The role of cell adhesion molecules in immunopathology. Immunol Today. 1994;15:251-255.
5. Cybulsky MI, Gimbrone MAJ. Endothelial-leukocyte adhesion molecules in acute inflammation and atherosclerosis. In: Simionescu N, Sinionescu M, eds. Endothelial Cell Dysfunctions. New York: Plenum Press; 1991:129-140.
6. Collins T, Cybulsky MI. NF-kB: pivotal mediator or innocent bystander in atherosclerosis? J Clin Invest. 2001;107:255-264.
7. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatant of cytokine-activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584-589.
8. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993;14:506-512.
9. Leeuwenberg JFM, Smeets EF, Neefjes MA, et al. E-selectin and intracellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology. 1992;77:543-549.
10. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791-804.
11. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
12. Rothlein R, Czajknowski M, O'Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol. 1988;141:1665-1669.
13. Szekanecz Z, Rhah MR, Pearce WH, Koch AE. Intracellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol 1994;98:337-343.
14. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-born monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181-190.
15. Gimbrone MAJ. Endothelial dysfunction and atherosclerosis. J Cardiac Surg. 1989;4:180-183.
16. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9-23.
17. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9:119-132.
18. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intracellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
19. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141:1427-1433.
20. DeGraba TJ, Siren AL, Penix L, et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke. 1998;29:1405-1410.
21. Hackman A, Abe Y, Insull W, et al. Levels of soluble adhesion molecules in patients with dyslipidemia. Circulation. 1996;93:1334-1338.
22. Mulvihill NT, Foley JB, Walsh MA, Crean PA. Relationship between intracoronary and peripheral expression of soluble cell adhesion molecules. Int J Cardiol. 2001;77:223-229.
23. Ghaisas N, Shahi C, Foley B, et al. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol. 1997;80:617-619.
24. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost. 1994;74:151-154.
25. van Tits LJ, de Waart F, Hak-Lemmers HL, et al. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radic Biol Med. 2001;30:1122-1129.
26. Calabresi L, Gomaraschi M, Villa B, Omoboni L, Dmitrieff C. Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol. 2002;22:650-655.
27. Mulvihill NT, Foley B, Murphy R, Crean P, Walsh M. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 2000;36:1210-1216.
28. Miwa K, Igawa A, Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res. 1997;36:37-44.
29. Ikada H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unsatable angina. Circulation. 1995;92:1693-1696.
30. Clark WM, Coul BM, Brily DP, Mainolfi E, Rothlein R. Circulating intracellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J Neuroimmunol. 1993;44:123-126.
31. Shyu K-G, Chang H, Lin C-C. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol. 1997;244:90-93.
32. Kase CS, Wolf PA, Chodosh EH, et al. Prevalence of silent stroke in patients presenting with initial stroke: The Framingham study. Stroke. 1989;20:850-852.
33. Jorgensen HS, Nakayam H, Raaschou HO, Gram J, Olsen TS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors and clinical significance: The Copenhagen Stroke Study. Stroke. 1994;25:97-104.
34. Matsubayashi K, Shimada K, Kawamato A, Ozawa T. Incidental brain lesions on magnetic resonance imaging and neurobehavioral functions in the apparently healthy elderly. Stroke. 1992;23:175-180.
35. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 1993;24:1631-1634.
36. Kawamura T, Umemura T, Kanai A, et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules. Diabetologia. 1998;41:911-917.
37. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol. 1993;21:537-545.
38. Murohara T, Kamijikkoku S, Honda T. Increased circulating soluble adhesion molecule-1 in acute myocardial infarction: a possible predictor of reperfusion ventricular arrhythmias. Crit Care Med. 2000;28:1861-1864.
39. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88-92.
40. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219-4225.
41. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
42. de Lemos JA, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol. 2000;36:423-426.
43. Peter Y, Naworth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlate with the extent of human atherosclerosis in contrast to circulating intracellular adhesion molecules-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 1997;17:505-512.
44. Dyerberg J, Bang HO, Stofferson E, Moncoda S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117-119.
45. Krumhout D, Bosschieter EB, Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
46. Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation. 1994;90:2248-2257.
47. Eritsland J, Arensen H, Gronseth K, Field NB, Abdelnoor M. Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery by pass operation. Results from SHOT study [Abstract]. Eur Heart J. 1994;15:29.
48. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000;71:213-223.
49. Massaro M, Carluccio MA, De Caterina R. Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia. 1999;44:507-513.
50. Weber C, Erl W, Pietsch A, Danesch U, Weber P. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol. 1995;15:622-628.
51. Miles EA, Wallace FA, Calder PC. Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis. 2000;152:43-50.
52. Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr. 1996;63:267-272.
53. Miles EA, Thies F, Wallace FA, et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci. 2001;100:91-100.
54. Johansen O, Seljeflot I, Hostmark AT, Arnesen H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 1999;19:1681-1686.
55. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J Nutr. 2001;131:366S-368S.
56. Erl W, Weber C, Wardermann C, Weber PC. Alpha-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol. 1997;273:H634-H640.
57. Martin A, Foxall T, Blumberg JB, Meydani M. Vitamin E inhibits low density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 1997;17:429-436.
58. Martin KR, Wu D, Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis. 2000;150:265-274.
59. Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr. 2001;73:941-948.
60. Faruqi R, de la Motte C, DiCorelto PE. α-Tocopherol inhibits against induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest. 1994;94:592-600.
61. Middleton EJ, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol. 1992;43:1167-1179.
62. Panes J, Gerritsen ME, Anderson DC, Miyasaka M, Granger DN. Apigenin inhibits tumor necrosis factor-induced intercellular adhesion molecule-1 up-regulation in vivo. Microcirculation. 1996;3:279-286.
63. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. 1995;147:278-292.
64. Stefanescu M, Matache C, Onu A, Szegli G. Modulation of cell adhesion by tyrosine kinases and phosphatases inhibitors. Roum Arch Microbiol Immunol. 1997;56:3-15.
65. Fruebis J, Silvestre M, Shelton D, Napoli C, Palinski W. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J Lipid Res. 1999;40:1958-1966.
66. Meydani M, Koga T, Zubik L, Ameho C, Kwan P. Vitamin E (E) supplementation reduces macrophage accumulation and suppresses endothelial cell (EC) expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. FASEB J. 2001;15:A246.
67. Goudev A, Kyurkchiev S, Gergova V, et al. Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles-a randomized double-blind study. Cardiology. 2000;94:227-232.
68. Ferns GA, Forster LA, Williams JC, et al. Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty. Ann Clin Biochem. 2000;37:649-654.
69. Scott DA, Stapleton JA, Wilson RF, et al. Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking. Blood Cell Mol Dis. 2000;26:255-258.
70. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000;23:733-738.
71. Skyrme-Jones RA, Meredith IT. Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes. Coron Artery Dis. 2001;12:69-75.
72. Gianetti J, Pedrinelli R, Petrucci R, et al. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J. 2002;143:467-474.